Adding targeted radiation to the main lung tumor for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial is testing whether giving focused radiation therapy to the main lung tumor, in addition to standard treatments like targeted therapy or chemo-immunotherapy, can help people with advanced lung cancer that has spread to many places. The goal is to see if adding this radiation can improve outcomes without causing too many side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of stage IV non-small cell lung cancer (cancer that has spread beyond the lung).
- Your cancer must have spread to more than five separate spots (this is not for people with only a few metastases).
- You must be newly diagnosed without any prior cancer treatment, or your cancer must be under control after either a short course of targeted therapy (like TKI) or a few months of chemo plus immunotherapy.
- You must be between 18 and 80 years old and be in reasonably good health (able to manage daily activities, with adequate organ function).
- You must not have other active cancers (except for certain curable ones), severe infections, uncontrolled heart problems, or be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with advanced non-small cell lung cancer whose tumors responded well to initial chemo-immunotherapy. Instead of giving full chest radiation, doctors will only target the main tumor to see if it can prevent regrowth with fewer side effects.
This trial tests whether focusing radiation only on the main tumor (not the surrounding area) is safe and effective for people with stage 3 lung cancer that cannot be removed with surgery. It aims to reduce side effects while keeping the treatment working.
This trial tests whether giving a short, high-dose blast of radiation to the main tumor before standard chemotherapy and radiation can help people with locally advanced lung cancer. It aims to improve how well the cancer is controlled while keeping side effects manageable.
This trial tests whether adding a high, focused dose of radiation to the usual first treatment (chemo and/or immunotherapy) can help people with non-small cell lung cancer that has spread to a limited number of spots (up to 5). The goal is to see if this approach improves how well the treatment works.
This trial tests whether giving radiotherapy to the main lung tumor, along with the usual medicines (like chemotherapy or immunotherapy), can help people with stage IV lung cancer. The goal is to see if adding this treatment helps control the cancer and improves how long patients live.
This trial tests if giving radiation to the main lung tumor before starting a targeted therapy pill can help delay the cancer from growing. It is for people with advanced non-small cell lung cancer that has a specific genetic change and who have not had targeted therapy before.
Hear when a new Non Small Cell Lung Cancer Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.